Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. [electronic resource]
Producer: 20150901Description: 96-105 p. digitalISSN:- 1879-0712
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Antioxidants -- pharmacology
- Biomarkers -- metabolism
- Body Weight -- drug effects
- Cholesterol -- adverse effects
- DNA Fragmentation -- drug effects
- Down-Regulation -- drug effects
- Flavanones -- pharmacology
- Inflammation Mediators -- metabolism
- Lipids -- blood
- Liver -- drug effects
- Male
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase 9 -- metabolism
- NF-kappa B -- metabolism
- Non-alcoholic Fatty Liver Disease -- chemically induced
- Rats
- Rats, Wistar
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.